Clinical Trial Update: MicroRNA Biomarkers for Neonatal Opioid Withdrawal Syndrome

View source ↗

Summary

A clinical trial sponsored by Milton S. Hershey Medical Center is recruiting to identify microRNA biomarkers for Neonatal Opioid Withdrawal Syndrome and Neonata…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neonatal Abstinence Syndrome
• Neonatal Opioid Withdrawal Syndrome

Snippet

Sponsor: Milton S. Hershey Medical Center | Conditions: Neonatal Opioid Withdrawal Syndrome, Neonatal Abstinence Syndrome | Status: RECRUITING